Table 1.
Vaccination schemes of the four studies
Study | Chickens | 1 st vaccination at day 0 | 2 nd vaccination at day 21 (studies 1 and 2) or at day 14 (studies 3 and 4) | Challenge | ||
---|---|---|---|---|---|---|
Vaccine | Dose | Vaccine | Dose | |||
1 | SPF | vFP2211 | 103 TCID50 | - | - | No |
H5N9 + FP MDA | vFP2211 | 103 TCID50 | - | - | ||
vFP2211 | 105 TCID50 | - | - | |||
vFP2211 | 105 TCID50 | inH5N9 | 0.5 mL | |||
- | - | inH5N9 | 0.5 mL | |||
2 | H5N9 + FP MDA | inH5N9 | 0.2 ml | inH5N9 | 0.5 mL | No |
vFP89 | 103 TCID50 | inH5N9 | 0.5 mL | |||
SPF | vFP89 | 103 TCID50 | inH5N9 | 0.5 mL | ||
3 | SPF | vFP89 | 103 TCID50 | inH5N9 | 0.3 mL | No |
- | - | inH5N9 | 0.3 mL | |||
H5N9 MDA | vFP89 | 103 TCID50 | inH5N9 | 0.3 mL | ||
- | - | inH5N9 | 0.3 mL | |||
FP | vFP89 | 103 TCID50 | inH5N9 | 0.3 mL | ||
- | - | inH5N9 | 0.3 mL | |||
H5(N8)* + H5N9 + FP MDA | vFP89 | 103 TCID50 | inH5N9 | 0.3 mL | ||
4 | SPF | - | - | - | - | Yes (D28) |
vFP89 | 103 TCID50 | - | - | |||
FP MDA | vFP89 | 103 TCID50 | inH5N9 | 0.3 mL | ||
- | - | inH5N9 | 0.3 mL | |||
H5N9 MDA | - | - | - | - | ||
vFP89 | 103 TCID50 | - | - | |||
vFP89 | 103 TCID50 | inH5N9 | 0.3 mL | |||
- | - | inH5N9 | 0.3 mL |
Chickens were hatched from unvaccinated (SPF) or vaccinated (MDA) hens. Chicks with H5N9, FP, H5N8 and/or H5N1 MDA were the progeny of hens vaccinated with inH5N9, fowlpox (FP), vFP89 (HA gene from A/turkey/Ireland/1378/83 [H5N8]) and/or vFP2211 (HA gene from A/chicken/Indonesia/7/2003 [H5N1]), respectively. The groups of 9 to 10 one-day-old birds received either vFP2211 or vFP89 or inH5N9 at D0, followed by a boost of inH5N9 at D21 (studies 1and 2) or at D14 (studies 3 and 4). In addition, a HPAI H5N1 challenge was performed in study 4.
*H5(N8) MDA are directed against the HA only of A/turkey/Ireland/1378/83 [H5N8]. Breeders of these chicks were indeed vaccinated with a fowlpox expressing the HA of H5N8 (vFP89).